Granite Point Capital Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-150,000
Closed -$5.69M 158
2020
Q3
$5.69M Buy
+150,000
New +$5.06M 0.31% 41

Other funds holding CDNA

Granite Point Capital Management's CDNA Position: Q1 2021 in Review

Granite Point Capital Management sold out of CareDx (CDNA) in Q1 2021, closing a stake of 140,000 shares — an estimated $10.1M sold.

Granite Point Capital Management first reported a position in CDNA in Q4 2017 and held it in 13 quarters. The position peaked at $10.1M in Q4 2020. 245 funds tracked by Wall St. Rank hold CDNA as of Q1 2021.

  • Granite Point Capital Management reported no remaining CareDx position as of Q1 2021 after selling out during the quarter.
  • Granite Point Capital Management sold 140,000 CareDx shares in Q1 2021, an estimated $10.1M.
  • Granite Point Capital Management first reported a position in CareDx in Q4 2017 and held it in 13 quarters.
  • Granite Point Capital Management's CareDx position peaked at $10.1M in Q4 2020.
  • 245 funds tracked by Wall St. Rank held CareDx as of Q1 2021.

Based on Granite Point Capital Management's 13F filing for Q1 2021, filed 12 May 2021.